ITIM
TXG icon

Indiana Trust & Investment Management’s 10x Genomics TXG Stock Holding History

Indiana Trust & Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$11.3K – 486
2024
Q1 		$11.3K Sell
300
-300
-50% -$13.2K ﹤0.01% 376
2023
Q4 		$33.6K Sell
600
-100
-14% -$4.35K 0.02% 285
2023
Q3 		$28.9K Buy
+700
New +$36.4K 0.01% 296

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Indiana Trust & Investment Management's TXG Position: Q2 2024 in Review

Indiana Trust & Investment Management sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 300 shares — an estimated $11.3K sold.

Indiana Trust & Investment Management first reported a position in TXG in Q3 2023 and held it in 3 quarters. The position peaked at $33.6K in Q4 2023. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Indiana Trust & Investment Management reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Indiana Trust & Investment Management sold 300 10x Genomics shares in Q2 2024, an estimated $11.3K.
  • Indiana Trust & Investment Management first reported a position in 10x Genomics in Q3 2023 and held it in 3 quarters.
  • Indiana Trust & Investment Management's 10x Genomics position peaked at $33.6K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2024, filed 10 Jul 2024.